Discover
EVH
Evolent Health, Inc.
3.69
4600 x 3.64
3700 x 3.64
bid
ask
+
0.02
0.54%
4150 @ 07:50 PM
3.68 -0.01 (0.27%)
| Ytd | -7.75% | |
| 1y | -57.78% |
3.63
day range
3.73
2.17
52 week range
9.61
| Open | 3.65 | Prev Close | 3.67 | Low | 3.63 | High | 3.73 | Mkt Cap | 417.19M |
| Vol | 2.56M | Avg Vol | 3.11M | EPS | -4.49 | P/E | N/A | Forward P/E | 6.01 |
| Beta | 0.73 | Short Ratio | 6.55 | Inst. Own | 108.70% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 4.46 | 200-d Avg | 3.85 | 1yr Est | 15.46 |
| Income Statement | |||
| Total Revenue | 652.52M | ||
| Revenues (USD) | 652.52M | ||
| Cost of Revenue | 571.68M | ||
| Gross Profit | 80.84M | ||
| Operating Expenses | 90.40M | ||
| Selling, General and Administrative Expense | 68.83M | ||
| Operating Income | -9.56M | ||
| Interest Expense | 16.86M | ||
| Income Tax Expense | 2.72M | ||
| Net Income | -28.36M | ||
| Net Income Common Stock | -28.36M | ||
| Net Income Common Stock (USD) | -28.36M | ||
| Consolidated Income | -28.36M | ||
| Earnings per Basic Share | -0.25 | ||
| Earnings per Basic Share (USD) | -0.25 | ||
| Earnings per Diluted Share | -0.25 | ||
| Earning Before Interest & Taxes (EBIT) | -8.79M | ||
| Earning Before Interest & Taxes (USD) | -8.79M | ||
| Weighted Average Shares | 112.54M | ||
| Weighted Average Shares Diluted | 112.54M | ||
| Balance Sheet | |||
| Cash and Equivalents | 141.47M | ||
| Cash and Equivalents (USD) | 141.47M | ||
| Investments | 8.76M | ||
| Investments Non-Current | 8.76M | ||
| Trade and Non-Trade Receivables | 449.12M | ||
| Current Assets | 610.51M | ||
| Property, Plant & Equipment Net | 84.63M | ||
| Total Assets | 1.97B | ||
| Debt Current | 1.54M | ||
| Total Debt | 970.43M | ||
| Current Liabilities | 492.83M | ||
| Debt Non-Current | 968.89M | ||
| Total Liabilities | 1.59B | ||
| Accumulated Retained Earnings (Deficit) | -1.37B | ||
| Accumulated Other Comprehensive Income | -3.63M | ||
| Shareholders Equity | 383.22M | ||
| Shareholders Equity (USD) | 383.22M | ||
| Assets Non-Current | 1.36B | ||
| Total Debt (USD) | 970.43M | ||
| Deferred Revenue | 1.21M | ||
| Goodwill and Intangible Assets | 1.25B | ||
| Liabilities Non-Current | 1.10B | ||
| Trade and Non-Trade Payables | 38.82M | ||
| Tax Liabilities | 118.85M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 21.57M | ||
| Net Cash Flow from Financing | -10.99M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -27.28M | ||
| Capital Expenditure | -6.85M | ||
| Issuance (Repayment) of Debt Securities | -10.99M | ||
| Net Cash Flow from Investing | -6.70M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 150.00K | ||
| Net Cash Flow from Operations | -9.31M | ||
| Effect of Exchange Rate Changes on Cash | -274.00K | ||
| Share Based Compensation | 15.20M | ||